Standard Biotools Inc Asset Turnover Ratio (LAB), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Standard Biotools Inc   (NASDAQ: LAB)
 

Standard Biotools Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Standard Biotools Inc 's asset turnover ratio, the ratio that measures the ability of Standard Biotools Inc 's assets to generate revenue, sequentially decreased to 0.14 in the second quarter (Jun 30 2026), which does not come as a surprise, as the Standard Biotools Inc continue to experience difficult business climate.

Within sector 9 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2037, from total ranking in the first quarter 2026 at 2676.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LAB Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 12.61 % 10.27 % -3.23 % -17.4 % -17.84 %
Y / Y Revenue Change -7.05 % -50.15 % -50.33 % -55.98 % -41.4 %
Asset Turnover Ratio (TTM) 0.14 0.15 0.19 0.23 0.26
LAB's Total Ranking # 2037 # 2676 # 2369 # 2477 #
Seq. Asset Change -1.86 % 12.57 % 5.21 % -3.11 % -3.9 %
Seq. Revenue Change -1 % -14.65 % 22.13 % -9.91 % -46.91 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 297
Overall Market # 2037

Asset Turnover Ratio Statistics
High Average Low
8.38 6.45 4.39
(Mar 31 2021)   (Dec 31 2025)




LAB Company Profile • Back to LAB Efficiency Comparisons • Compare LAB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Gossamer Bio Inc   0.36 $ 53.286  Millions$ 146.709  Millions
Ionis Pharmaceuticals Inc   0.36 $ 1,169.419  Millions$ 3,238.360  Millions
Bionexus Gene Lab Corp   0.36 $ 3.127  Millions$ 8.660  Millions
Sensus Healthcare Inc   0.36 $ 18.294  Millions$ 51.035  Millions
Innovative Eyewear Inc   0.36 $ 3.412  Millions$ 9.567  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,105.000  Millions$ 40,125.250  Millions
Invo Fertility Inc   0.34 $ 7.531  Millions$ 22.386  Millions
Pelthos Therapeutics Inc   0.32 $ 43.304  Millions$ 134.891  Millions
Opko Health Inc   0.31 $ 587.896  Millions$ 1,903.425  Millions
Pfizer Inc  0.31 $ 63,696.000  Millions$ 206,410.000  Millions
Sonida Senior Living Inc   0.31 $ 525.973  Millions$ 1,718.907  Millions
Orchestra Biomed Holdings Inc   0.29 $ 31.976  Millions$ 109.006  Millions
Immunitybio inc   0.29 $ 165.792  Millions$ 574.007  Millions
Amarin Corp Plcuk  0.29 $ 186.480  Millions$ 650.179  Millions
Orasure Technologies Inc  0.29 $ 111.978  Millions$ 391.497  Millions
Maravai Lifesciences Holdings Inc   0.28 $ 207.886  Millions$ 734.183  Millions
Adc Therapeutics Sa  0.27 $ 79.584  Millions$ 295.946  Millions
Repligen Corp  0.27 $ 785.101  Millions$ 2,938.591  Millions
Hcw Biologics Inc   0.26 $ 6.843  Millions$ 26.019  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.000  Millions$ 10,078.725  Millions
Plus Therapeutics Inc   0.24 $ 4.203  Millions$ 17.235  Millions
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions
Retractable Technologies Inc  0.24 $ 33.488  Millions$ 142.089  Millions
Bio Green Med Solution Inc   0.23 $ 1.861  Millions$ 7.940  Millions
Personalis Inc   0.23 $ 69.669  Millions$ 303.633  Millions
Petvivo Holdings Inc   0.23 $ 1.182  Millions$ 5.211  Millions
Biocorrx Inc   0.23 $ 0.787  Millions$ 3.478  Millions
Cannapharmarx Inc   0.21 $ 1.699  Millions$ 8.027  Millions
Beyond Air Inc   0.21 $ 6.677  Millions$ 32.326  Millions
Ideaya Biosciences Inc   0.20 $ 234.127  Millions$ 1,158.627  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.